That's right. But, to be fair, when someone is wrong over and over and over again, then gloats how much they made on their investment, it does raise questions.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025